Additionally, CD8+ cells are eliminated by tumor-associated macrophages (TAMs), which induce a tolerant tumor microenvironment formation in BLCA [19], and infiltrating levels of TAMs may predict a poor prognosis of NMIBC following Bacille Calmette-Guerin (BCG) infusion therapy [46]. This evidence concerns the gene CD8A and neoplasm.